Your browser doesn't support javascript.
loading
Reversal of IKZF1-induced glucocorticoid resistance by dual targeting of AKT and ERK signaling pathways.
Butler, Miriam; Vervoort, Britt M T; van Ingen Schenau, Dorette S; Jongeneel, Lieneke; van der Zwet, Jordy C G; Marke, René; Meijerink, Jules P P; Scheijen, Blanca; van der Meer, Laurens T; van Leeuwen, Frank N.
Afiliação
  • Butler M; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Vervoort BMT; Laboratory of Pediatric Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.
  • van Ingen Schenau DS; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Jongeneel L; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • van der Zwet JCG; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Marke R; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Meijerink JPP; Laboratory of Pediatric Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.
  • Scheijen B; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • van der Meer LT; Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands.
  • van Leeuwen FN; Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands.
Front Oncol ; 12: 905665, 2022.
Article em En | MEDLINE | ID: mdl-36119546

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article